Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.41 |
| ▸ | CDC14B | O60729 | 2/20 | 0.41 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30055113 | 1.00 | LPL (0.41) | LPLLIPGCDC14BCDC14ACYP19A1 | |
| SCHEMBL20462444 | 0.91 | CDC14B (0.44) | LPLLIPGCDC14BCDC14ACYP19A1 | |
| SCHEMBL26313153 | 0.90 | LPL (0.39) | LPLLIPGCDC14BCDC14ACYP19A1 | |
| SCHEMBL23046808 | 0.89 | ALOX5 (0.44) | LPLLIPGCDC14BCDC14ACYP19A1 | |
| SCHEMBL21662932 | 0.88 | TSHR (0.37) | LPLLIPGCDC14BCDC14ACYP19A1 | |
| SCHEMBL21662964 | 0.88 | LPL (0.35) | LPLLIPGCDC14BCDC14AMEN1 | |
| SCHEMBL22376916 | 0.87 | ALOX5 (0.35) | LPLLIPGCDC14BCDC14AMEN1 | |
| SCHEMBL22376011 | 0.87 | ALOX5 (0.36) | LPLLIPGCDC14BCDC14AMEN1 | |
| SCHEMBL22376882 | 0.87 | ALOX5 (0.36) | LPLLIPGCDC14BCDC14AMEN1 | |
| SCHEMBL23046805 | 0.86 | ALOX5 (0.44) | LPLLIPGCDC14BCDC14AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-11-05 | — | — | US | disclosed |
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, OR10J3 | LPL 3161/4885LIPG 1293/4885CDC14B 3634/4885 |
| US-20200039971-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | LPL 3201/4885LIPG 3603/4885CDC14B 4134/4885 |
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, OR10J3 | LPL 3161/4885LIPG 1293/4885CDC14B 3634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.